MAPT and Alzheimer disease: As compared to the original biosensor line, the stable pseudoacetylated (EAAAK)3 expressing cell population demonstrated a ~ tenfold enhanced, robust ability to detect seed competent tau in human AD brain homogenate (Fig. 1E; Fig. 2).